This Hershey Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

B. Riley Securities analyst Eric Wold downgraded the rating for Cinemark Holdings, Inc. CNK from Buy to Neutral and maintained the price target of $31. Cinemark shares gained 1.3% to close at $28.17 on Monday. See how other analysts view this stock.
Citigroup analyst Thomas Palmer downgraded The Hershey Company HSY from Neutral to Sell and slashed the price target from $195 to $182. Hershey shares rose 0.04% to close at $196.41 on Monday. See how other analysts view this stock.
Alembic Global analyst Peter Skibitski downgraded the rating for Northrop Grumman Corporation NOC from Overweight to Neutral and announced a price target of $560. Northrop Grumman shares gained 0.5% to close at $512.00 on Monday. See how other analysts view this stock.
Citigroup analyst Alicia Yap downgraded PDD Holdings Inc. PDD from Buy to Neutral and cut the price target from $194 to $120. PDD shares dipped 28.5% to settle at $100.00 on Monday. See how other analysts view this stock.
Maxim Group analyst Jason McCarthy downgraded the rating for Cyclo Therapeutics, Inc. CYTH from Buy to Hold. Cyclo Therapeutics shares rose 6.1% to close at $0.8277 on Monday. See how other analysts view this stock.